Beigene LtdNASDAQ:BGNE
- LAST PRICE187.4900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots185.0000/ 8
- Ask / Lots195.0000/ 3
- Open / Previous Close186.9400 / 187.4900
- Day Range
- 52 Week Range
- Volume210,015
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BGNE |
|---|---|---|
| 09:32 ET | 3033 | 186.49 |
| 09:33 ET | 675 | 186.87 |
| 09:35 ET | 100 | 186.9 |
| 09:37 ET | 300 | 186.91 |
| 09:39 ET | 1500 | 188.085 |
| 09:42 ET | 200 | 188.86 |
| 09:46 ET | 200 | 188.5025 |
| 09:50 ET | 200 | 188.48 |
| 09:51 ET | 533 | 186.205 |
| 09:55 ET | 500 | 187.94 |
| 09:57 ET | 2670 | 188.345 |
| 10:00 ET | 915 | 187.46 |
| 10:02 ET | 100 | 187.46 |
| 10:06 ET | 2831 | 187.975 |
| 10:08 ET | 800 | 188.15 |
| 10:09 ET | 1307 | 188.145 |
| 10:11 ET | 1003 | 187.905 |
| 10:13 ET | 3900 | 188.04 |
| 10:15 ET | 1000 | 187.55 |
| 10:18 ET | 100 | 187.565 |
| 10:20 ET | 100 | 187.195 |
| 10:22 ET | 100 | 187.565 |
| 10:24 ET | 400 | 187.95 |
| 10:26 ET | 600 | 188.245 |
| 10:27 ET | 200 | 188.29 |
| 10:29 ET | 100 | 188.23 |
| 10:31 ET | 1400 | 187.8251 |
| 10:33 ET | 200 | 187.84 |
| 10:36 ET | 300 | 188.265 |
| 10:38 ET | 350 | 188.135 |
| 10:40 ET | 500 | 187.77 |
| 10:42 ET | 900 | 187.735 |
| 10:45 ET | 445 | 188.06 |
| 10:47 ET | 1300 | 188.275 |
| 10:49 ET | 2095 | 187.77 |
| 10:51 ET | 500 | 188.21 |
| 10:54 ET | 100 | 188.66 |
| 10:56 ET | 200 | 188.68 |
| 10:58 ET | 800 | 188.12 |
| 11:00 ET | 2311 | 188.125 |
| 11:02 ET | 550 | 187.78 |
| 11:03 ET | 147 | 188.0228 |
| 11:05 ET | 212 | 187.74 |
| 11:07 ET | 200 | 187.85 |
| 11:12 ET | 100 | 187.82 |
| 11:14 ET | 1802 | 188.98 |
| 11:16 ET | 1300 | 189.03 |
| 11:18 ET | 100 | 189.11 |
| 11:20 ET | 200 | 188.94 |
| 11:21 ET | 500 | 188.95 |
| 11:23 ET | 100 | 189.105 |
| 11:25 ET | 900 | 189 |
| 11:27 ET | 700 | 189.175 |
| 11:30 ET | 400 | 189.01 |
| 11:32 ET | 400 | 189.12 |
| 11:34 ET | 100 | 188.785 |
| 11:38 ET | 300 | 188.68 |
| 11:39 ET | 312 | 187.88 |
| 11:43 ET | 100 | 187.805 |
| 11:45 ET | 500 | 188.35 |
| 11:50 ET | 400 | 188.08 |
| 11:52 ET | 100 | 188.46 |
| 11:54 ET | 200 | 188.46 |
| 11:56 ET | 100 | 188.255 |
| 11:57 ET | 200 | 188.13 |
| 11:59 ET | 200 | 188.125 |
| 12:01 ET | 200 | 188.02 |
| 12:06 ET | 635 | 188.305 |
| 12:08 ET | 100 | 188.32 |
| 12:10 ET | 600 | 188.405 |
| 12:12 ET | 518 | 188.47 |
| 12:14 ET | 100 | 188.445 |
| 12:15 ET | 566 | 188.1325 |
| 12:19 ET | 100 | 188.42 |
| 12:21 ET | 100 | 188.41 |
| 12:24 ET | 200 | 188.155 |
| 12:26 ET | 300 | 188.185 |
| 12:28 ET | 100 | 188.44 |
| 12:30 ET | 600 | 188.79 |
| 12:32 ET | 1365 | 188.785 |
| 12:33 ET | 2750 | 188.28 |
| 12:35 ET | 100 | 188.19 |
| 12:42 ET | 4617 | 187.665 |
| 12:44 ET | 200 | 187.41 |
| 12:48 ET | 100 | 187.54 |
| 12:50 ET | 100 | 187.645 |
| 12:57 ET | 400 | 187.3 |
| 01:00 ET | 100 | 187.2 |
| 01:02 ET | 374 | 187.085 |
| 01:04 ET | 100 | 187.33 |
| 01:06 ET | 100 | 187.01 |
| 01:08 ET | 900 | 186.92 |
| 01:13 ET | 100 | 187.41 |
| 01:15 ET | 100 | 187.42 |
| 01:18 ET | 800 | 187.415 |
| 01:20 ET | 257 | 187.385 |
| 01:22 ET | 300 | 186.94 |
| 01:24 ET | 100 | 187.205 |
| 01:26 ET | 100 | 187.22 |
| 01:27 ET | 200 | 187.22 |
| 01:29 ET | 100 | 187.21 |
| 01:31 ET | 100 | 186.91 |
| 01:33 ET | 100 | 186.7 |
| 01:36 ET | 300 | 187.24 |
| 01:38 ET | 100 | 187.42 |
| 01:42 ET | 100 | 187.415 |
| 01:44 ET | 508 | 187.44 |
| 01:45 ET | 100 | 187.42 |
| 01:49 ET | 100 | 187.67 |
| 01:51 ET | 100 | 187.615 |
| 01:54 ET | 421 | 187.355 |
| 01:56 ET | 100 | 187.585 |
| 01:58 ET | 200 | 187.595 |
| 02:00 ET | 100 | 187.485 |
| 02:02 ET | 100 | 187.595 |
| 02:05 ET | 1497 | 186.835 |
| 02:07 ET | 100 | 186.85 |
| 02:09 ET | 683 | 186.825 |
| 02:12 ET | 200 | 186.625 |
| 02:14 ET | 1899 | 186.78 |
| 02:16 ET | 100 | 186.78 |
| 02:18 ET | 410 | 186.655 |
| 02:20 ET | 100 | 186.8 |
| 02:21 ET | 1600 | 186.45 |
| 02:25 ET | 200 | 186.535 |
| 02:27 ET | 100 | 186.53 |
| 02:30 ET | 400 | 186.545 |
| 02:32 ET | 300 | 186.3 |
| 02:38 ET | 200 | 186.325 |
| 02:39 ET | 650 | 186.3765 |
| 02:45 ET | 100 | 186.32 |
| 02:48 ET | 500 | 186.68 |
| 02:50 ET | 200 | 186.775 |
| 02:52 ET | 700 | 186.32 |
| 02:54 ET | 100 | 186.24 |
| 02:56 ET | 400 | 186.29 |
| 02:57 ET | 700 | 186.57 |
| 02:59 ET | 604 | 187 |
| 03:01 ET | 200 | 186.975 |
| 03:06 ET | 200 | 186.98 |
| 03:08 ET | 200 | 186.685 |
| 03:10 ET | 1258 | 186.82 |
| 03:12 ET | 200 | 186.82 |
| 03:14 ET | 631 | 187.45 |
| 03:17 ET | 641 | 187.19 |
| 03:19 ET | 200 | 187.125 |
| 03:21 ET | 200 | 186.745 |
| 03:24 ET | 400 | 187.12 |
| 03:26 ET | 1166 | 187.05 |
| 03:28 ET | 300 | 187.12 |
| 03:30 ET | 200 | 186.85 |
| 03:32 ET | 539 | 186.865 |
| 03:33 ET | 700 | 187.065 |
| 03:35 ET | 500 | 187.2 |
| 03:37 ET | 1500 | 187.08 |
| 03:39 ET | 200 | 187.09 |
| 03:42 ET | 715 | 187.165 |
| 03:44 ET | 800 | 187.03 |
| 03:46 ET | 817 | 187.045 |
| 03:48 ET | 900 | 186.83 |
| 03:50 ET | 800 | 186.895 |
| 03:51 ET | 1700 | 187.22 |
| 03:53 ET | 1000 | 187.28 |
| 03:55 ET | 3516 | 187.73 |
| 03:57 ET | 1934 | 187.815 |
| 04:00 ET | 4949 | 187.49 |
Nov 29, 2023
BeiGene to Host ASH Investor Meeting in Person and via Webcast on December 10, 2023, from 4:01PM ET on Wednesday Nov 29, 2023 by Dow Jones
4:01PM ET on Wednesday Nov 29, 2023 by Dow Jones
Nov 28, 2023
BeiGene to Present New Data Highlighting Hematology Portfolio and Pipeline Strengths at ASH 2023, from 6:00AM ET on Tuesday Nov 28, 2023 by Dow Jones
6:00AM ET on Tuesday Nov 28, 2023 by Dow Jones
Nov 21, 2023
BeiGene and Ensem Therapeutics Announce Partnership to Advance Differentiated CDK2 Inhibitor, from 6:00AM ET on Tuesday Nov 21, 2023 by Dow Jones
6:00AM ET on Tuesday Nov 21, 2023 by Dow Jones
Nov 17, 2023
Nov 13, 2023
DJ BeiGene's Global Sales Outlook Brightens -- Market Talk, from 11:24PM ET on Monday Nov 13, 2023 by Dow Jones
11:24PM ET on Monday Nov 13, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Beigene Ltd | 20.4B | -20.2x | --- |
Alnylam Pharmaceuticals Inc | 21.5B | -41.1x | --- |
Biomarin Pharmaceutical Inc | 17.4B | 120.3x | --- |
Neurocrine Biosciences Inc | 11.5B | 62.6x | --- |
argenx SE | 26.8B | -109.3x | --- |
Exact Sciences Corp | 12.1B | -42.4x | --- |
Company Information
BeiGene, Ltd. is a global biotechnology company. The Company is focused on developing and commercializing oncology medicines to improve treatment outcomes and expand access for patients worldwide. The Company has discovered and developed three approved medicines including, BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; tislelizumab, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and pamiparib, a selective small molecule inhibitor of PARP1 and PARP2. BRUKINSA is a second-generation small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) designed to maximize BTK occupancy and minimize off-target binding effects. It has obtained approvals to market BRUKINSA in the United States, China, the European Union, the United Kingdom, Canada and Australia. The Company has in-licensed the rights to distribute 13 approved medicines for the China market.
Contact Information
- Headquarters
- 94 Solaris Avenue,, Camana BayGRAND CAYMAN, BEJ, Cayman Islands KY1-1108
- Phone
- 345-949-4123
- Fax
- ---
Executives
- Co-Founder, Executive Chairman of the Board, Chief Executive Officer
- John Oyler
- President, Chief Operating Officer, General Manager - China
- Xiaobin Wu
- Co-Founder, Non-Executive Director
- Xiaodong Wang
- Chief Financial Officer
- Julia Wang
- Global Head of R&D
- Lai Wang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $20.4B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 104.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.57 |
EPS | $-9.26 |
Book Value | $45.91 |
P/E Ratio | -20.2x |
Price/Sales (TTM) | 9.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -58.63% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
